secwatch / observer
8-K filed October 10, 2023, 7:59 PM ET ticker LNAI CIK 0001527728
leadership confidence high sentiment neutral materiality 0.50

Renovaro Biosciences appoints Leni Boeren and Ruud Hendriks as independent directors

Lunai Bioworks Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leni Boeren

Independent Director
LNAI · Lunai Bioworks Inc.
Effective
2023-10-04
Filed
October 10, 2023, 7:59 PM ET
increased the size of the Board to ten members and appointed Leni Boeren and Ruud Hendriks to the Board effective immediately, to fill vacancies created.
Appointed

Ruud Hendriks

Independent Director
LNAI · Lunai Bioworks Inc.
Effective
2023-10-04
Filed
October 10, 2023, 7:59 PM ET
increased the size of the Board to ten members and appointed Leni Boeren and Ruud Hendriks to the Board effective immediately, to fill vacancies created.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leni Boeren was appointed as Independent Director at Lunai Bioworks Inc..

Action
appointed
Role
Independent Director
Exact text from the filing
increased the size of the Board to ten members and appointed Leni Boeren and Ruud Hendriks to the Board effective immediately, to fill vacancies created.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ruud Hendriks was appointed as Independent Director at Lunai Bioworks Inc..

Action
appointed
Role
Independent Director
Exact text from the filing
increased the size of the Board to ten members and appointed Leni Boeren and Ruud Hendriks to the Board effective immediately, to fill vacancies created.
View on SEC.gov

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR
accession 0001731122-23-001825
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.